Zinc in PDB 3su5: Crystal Structure of NS3/4A Protease Variant D168A in Complex with Vaniprevir

The structure of Crystal Structure of NS3/4A Protease Variant D168A in Complex with Vaniprevir, PDB code: 3su5 was solved by C.A.Schiffer, K.P.Romano, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	30.01 / 1.55
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	55.066, 58.538, 60.015, 90.00, 90.00, 90.00
R / Rfree (%)	16.5 / 18.3

The binding sites of Zinc atom in the Crystal Structure of NS3/4A Protease Variant D168A in Complex with Vaniprevir (pdb code 3su5). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of NS3/4A Protease Variant D168A in Complex with Vaniprevir, PDB code: 3su5:

Zinc binding site 1 out of 1 in the Crystal Structure of NS3/4A Protease Variant D168A in Complex with Vaniprevir


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of NS3/4A Protease Variant D168A in Complex with Vaniprevir within 5.0Å range: probe atom residue distance (Å) B Occ A:Zn6 b:20.0 occ:1.00 SG A:CYS1145 2.3 16.0 1.0 SG A:CYS1099 2.3 20.8 1.0 SG A:CYS1097 2.3 16.9 1.0 ND1 A:HIS1149 2.4 24.0 1.0 CB A:CYS1099 3.0 19.0 1.0 CB A:CYS1145 3.3 13.2 1.0 CB A:CYS1097 3.4 14.9 1.0 CG A:HIS1149 3.4 21.5 1.0 CE1 A:HIS1149 3.4 25.3 1.0 CB A:HIS1149 3.5 17.6 1.0 N A:CYS1099 3.8 18.5 1.0 CA A:CYS1097 3.8 15.6 1.0 CA A:CYS1099 4.0 19.1 1.0 N A:THR1098 4.2 17.9 1.0 C A:CYS1097 4.4 17.1 1.0 CD2 A:HIS1149 4.5 25.0 1.0 NE2 A:HIS1149 4.5 26.0 1.0 CA A:HIS1149 4.7 16.4 1.0 CB A:ALA1147 4.7 18.6 1.0 N A:HIS1149 4.7 16.3 1.0 CA A:CYS1145 4.7 13.6 1.0 O A:HOH183 4.9 37.4 1.0 C A:THR1098 4.9 19.3 1.0 O A:HOH71 4.9 35.9 1.0

K.P.Romano, A.Ali, C.Aydin, D.Soumana, A.Ozen, L.M.Deveau, C.Silver, H.Cao, A.Newton, C.J.Petropoulos, W.Huang, C.A.Schiffer. The Molecular Basis of Drug Resistance Against Hepatitis C Virus NS3/4A Protease Inhibitors. Plos Pathog. V. 8 02832 2012.
ISSN: ISSN 1553-7366
PubMed: 22910833
DOI: 10.1371/JOURNAL.PPAT.1002832